Print This Page

Home Health & Medicine Pharmaceutical Intermediate

High Purity 99% Powder CAS 27262-47-1 Local Anesthetic Base Levobupivacaine for Pain Relief pictures & photos

High Purity 99% Powder CAS 27262-47-1 Local Anesthetic Base Levobupivacaine for Pain Relief

Powder:	Yes
Customized:	Customized
Certification:	ISO 9001, USP, BP
Suitable for:	Adult
State:	Powder
Purity:	>99%

Samples:	US$ 200/kg 1 kg(Min.Order) \| Request Sample

Customization:	Available \| Customized Request

Contact Supplier

Contact Now

Inquiry Basket

Suzhou Greenway Biotech Co., Ltd.

Manufacturer/Factory, Trading Company

Diamond Member Since 2017

Suppliers with verified business licenses

Rating: 5.0/5

Jiangsu, China

Audited Supplier

High Repeat Buyers Choice

More than 50% of buyers repeatedly choose the supplier

Exhibition Experience

The supplier had participated in offline trade shows, you can check the Audit Report for more information

In-stock Capacity

The supplier has In-stock capacity

Fast Delivery

The supplier can deliver the goods within 30 days

to see all verified strength labels (11)

Product Description

Company Info.

Basic Info.

Model NO.

A-217

Sample

Available

MOQ

1kg

Appearance

White Powder

Assay

99%

Test Method

HPLC

Shelf Life

2 Years

Storage

Cool&Dry Places

Packing

1kg/Bag; 25kg/Drum

CAS No.

27262-47-1

Molecular Formula

C18h28n2o

Molecular Weight

288.43

Grade

Pharmaceutical Grade

Application

Pharmaceutical

Coa

Available

MSDS

Available

Transport Package

1kg/Bag; 25kg/Drum

Specification

1kg/Bag; 25kg/Drum

Trademark

Greenway

Origin

Jiangsu

HS Code

2942000000

Production Capacity

500kg/Week

Product Description

High Purity 99% Powder CAS 27262-47-1 Local Anesthetic Base Levobupivacaine for Pain Relief

Product Name	Levobupivacaine
CAS No.	27262-47-1
Molecular Formula	C18H28N2O
Molecular Weight	288.43
Appearance	White Powder
Assay	99%
Grade	Pharmaceutical Grade
Brand	Greenway

Product Functions&Applciations:
Clinical Use:
Compared to bupivacaine, levobupivacaine is associated with less vasodilation and has a longer duration of action. It is approximately 13 percent less potent (by molarity) than racemic bupivacaine and has a longer motor block onset time.
Indications:
Levobupivacaine is indicated for local anaesthesia including infiltration, nerve block, ophthalmic, epidural and intrathecal anaesthesia in adults; and infiltration analgesia in children.
Contraindications:
Levobupivacaine is contraindicated for IV regional anaesthesia (IVRA).

Levobupivacaine (rINN) is a local anaesthetic drug belonging to the amino amide group. It is the S-enantiomer of bupivacaine.

The hydrochloride salt of levobupivacaine, an amide derivative with anesthetic property. Levobupivacaine reversibly binds voltage-gated sodium channels to modulate ionic flux and prevent the initiation and transmission of nerve impulses (stabilizing neuronal membrane), thereby resulting in analgesia and anesthesia. In comparison with racemic bupivacaine, levobupivacaine is associated with less vasodilation and has a longer duration of action.

High Purity 99% Powder CAS 27262-47-1 Local Anesthetic Base Levobupivacaine for Pain Relief